|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$55,958.22 |
2.83% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$53,969.84 |
2.73% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$52,429.74 |
2.65% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$51,959.10 |
2.62% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$49,826.88 |
2.52% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$48,495.77 |
2.45% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$47,656.85 |
2.41% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,652.67 |
2.36% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$46,465.98 |
2.35% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$44,695.98 |
2.26% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$44,484.68 |
2.25% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$43,747.50 |
2.21% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$43,073.95 |
2.18% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$42,994.69 |
2.17% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$42,732.72 |
2.16% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$41,886.04 |
2.12% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$41,857.26 |
2.11% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$41,351.76 |
2.09% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$40,910.16 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$40,971.51 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$40,947.84 |
2.07% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$41,005.55 |
2.07% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$40,958.40 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,679.67 |
2.05% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$40,310.40 |
2.04% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$39,252.90 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$38,785.13 |
1.96% |
| Steris Plc |
STE |
G8473T100 |
177 |
$38,621.40 |
1.95% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$38,260.32 |
1.93% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,909.83 |
1.91% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$37,878.64 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$37,396.80 |
1.89% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$37,518.69 |
1.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$37,062.87 |
1.87% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$36,912.34 |
1.86% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$36,056.36 |
1.82% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$35,481.12 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$35,485.48 |
1.79% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$35,273.97 |
1.78% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$35,287.84 |
1.78% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,238.86 |
1.78% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$34,852.20 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,532.42 |
1.74% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$32,896.00 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,679.24 |
1.65% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,809.32 |
1.56% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$30,020.24 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,754.18 |
1.45% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$26,906.04 |
1.36% |
| US Dollar |
$USD |
|
9,615 |
$9,615.12 |
0.49% |
| New Zealand Dollar |
$NZD |
|
799 |
$455.46 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|